Phibro Animal Health (PAHC) Return on Invested Capital (2013 - 2026)

Phibro Animal Health's Return on Invested Capital history runs 14 years deep, the most recent figure standing at 0.02% for Q1 2026.

• On a quarterly basis, Return on Invested Capital rose 3.0% year-over-year to 0.02% in Q1 2026; TTM through Mar 2026 was 0.02%, a 3.0% increase from a year earlier, with the FY2025 full-year figure at 0.03%, changed 0.0% from the prior year.
• Return on Invested Capital was little changed at 0.02% in Q1 2026 per PAHC's latest filing, from 0.02% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.16% in Q3 2024 and bottomed at 4.7% in Q4 2024.
• The 5-year median for Return on Invested Capital is 0.01% (2022), against an average of 0.26%.
• Across the five-year window, Return on Invested Capital sank 470 bps in 2024 and jumped 471 bps in 2025, its largest moves.
• Year by year, Return on Invested Capital stood at 0.01% in 2022, then slumped by 64 bps to 0.0% in 2023, then tumbled by 128762 bps to 4.7% in 2024, then soared by 100 bps to 0.02% in 2025, then grew by 0 bps to 0.02% in 2026.
• Per Business Quant, the three latest PAHC Return on Invested Capital figures stand at 0.02% (Q1 2026), 0.02% (Q4 2025), and 0.02% (Q3 2025).